In the developing pancreas, self-renewal of progenitors and patterning of cell fates are coordinated to ensure the correct size and cellular makeup of the organ. How this coordination is achieved, however, is not clear. We report that deletion of DNA methyltransferase 1 (Dnmt1) in pancreatic progenitors results in agenesis of the pancreas due to apoptosis of progenitor cells. We show that DNMT1 is bound to the p53 regulatory region and that loss of Dnmt1 results in derepression of the p53 locus. Haploinsufficiency of p53 rescues progenitor cell survival and cellular makeup of the Dnmt1-deleted pancreas.
The vertebrate pancreas is a complex organ made of functionally different tissue types that arise from a common progenitor cell pool during embryogenesis (Gu et al. 2003; Jensen 2004; Gittes 2009 ). Lineage tracing analysis indicates that a pool of pancreatic progenitor cells persists throughout organogenesis to give rise to differentiated mature cell types in a spatially and temporally regulated manner (Herrera 2000; Jensen et al. 2000a; Gu et al. 2002) . The maintenance of the progenitor cell pool requires that progenitor cell self-renewal is balanced with cell cycle exit to coordinate differentiation of mature cell types of the pancreas (Georgia et al. 2006) .
DNA methylation is a potential epigenetic mechanism that may be involved in maintaining the balance between self-renewal and terminal differentiation in the developing pancreas. DNA methylation may serve as a means of repressing pluripotency genes in multipotent progenitor cells or a means of repressing lineage-specific differentiation genes in multipotent progenitor cells (Reik 2007) . It is not clear whether pancreatic progenitor DNA methylation patterns must be inherited during self-renewal to maintain a functional progenitor population by repressing differentiation genes or to serve as a basis for establishing lineage-specific methlylation patterns during differentiation.
DNA methyltransferase 1 (Dnmt1) is the enzyme that propagates DNA methylation patterns during cell division. Previous studies on Dnmt1 have yielded interesting yet divergent data about its role in maintenance and differentiation of progenitor cell types. Dnmt1-null mouse embryonic stem cells (mESCs) undergo limited differentiation and apoptosis and are eliminated in competition assays with wild-type mESCs yet have a proliferative capacity comparable with that of wild-type mESCs when maintained in an undifferentiated state (Lei et al. 1996; Panning and Jaenisch 1996) . Dnmt1-null embryos expire from growth arrest and severe neural tube distortions by embryonic day 8.5 (E8.5), which indicates that Dnmt1-null mESCs are capable of undergoing more extensive differentiation in vivo than in vitro (Li et al. 1992 ; Lei et al. 1996) . Loss of Dnmt1 in hematopoetic progenitor cells results in defects in self-renewal and niche retention and an inappropriate shift to myeloid progenitor cell cycling and differentiation (Trowbridge et al. 2009 ). Studies in human adult epidermal stem cells indicate that Dnmt1 maintains progenitor self-renewal by repressing genes that trigger cell cycle exit and premature differentiation (Sen et al. 2010) . During neurogenesis, Dnmt1 restricts precocious astrogliogenesis of neural precursor cells, but deletion of Dnmt1 in telencephalic precursors results in cell death and forebrain degeneration (Fan et al. 2005; Hutnick et al. 2009 ). Taken together, these studies present context-dependent roles for Dnmt1 that may have differential effects in vitro or in vivo.
To investigate the in vivo role of DNMT1 in progenitor maintenance and concomitant lineage specification during organogenesis, we conditionally deleted Dnmt1 in pancreatic progenitor cells. Analysis of progenitor cell self-renewal dynamics revealed that Dnmt1-null pancreatic progenitor cells undergo G2 arrest. Our studies indicate that DNMT1 functions to repress p53. In its absence, p53 expression is derepressed, resulting in apoptosis of pancreatic progenitor cells. We show that p53 haploinsufficiency rescues progenitor cell survival and restores pancreatic organogenesis in the Dnmt1-null embryos. These data suggest that Dnmt1 is required to prevent p53-dependent apoptosis during lineage specification of pancreatic progenitor cells.
Results and Discussion

Loss of Dnmt1 results in a severely atrophic pancreas
We bred mice with a floxed allele of Dnmt1 (DNMT1 fl/fl ) with mice transgenic for Cre recombinase under the control of the Pdx1 promoter (Jackson-Grusby et al. 2001; Gu et al. 2002) . This restricted Dnmt1 excision to the pancreatic epithelium (DNMT1 PC ). To facilitate lineage tracing studies, we also bred in the stop-floxed-R26R YFP to mark all cells derived from progenitor cells that expressed the Pdx1-Cre transgene (Srinivas et al. 2001) . To confirm that deletion of Dnmt1 resulted in hypomethylation of the self-renewing pancreatic progenitor pool, we used immunohistochemistry to detect 5-methyl-cytosine (5mC). Unlike the control epithelium, where 5mC uniformly stained the epithelium and surrounding mesenchyme, 5mC staining was grossly diminished in the epithelium of the DNMT1 PC pancreas but maintained in the surrounding mesenchyme (Supplemental Fig. 1A,B) . This indicated that deletion of Dnmt1 resulted in hypomethylation of the pancreatic epithelium during organogenesis. Previous reports have shown that loss of Dnmt1 leads to derepression of intracisternal A particle (IAP), a core retroviral element protein (Fan et al. 2001) . Consistent with these previous studies, IAP staining was not detected in the pancreatic epithelium of control E13.5 embryos, but high levels of IAP were detected in the DNMT1 PC pancreatic epithelium (Supplemental Fig. 1C,D) . Some glucagon-positive cells in the DNMT1 PC pancreatic epithelium were negative for IAP expression and were likely derived from cells that had escaped Cremediated recombination. These data indicated that Pdx1-Cre expression efficiently deleted Dnmt1 from the large majority of pancreatic progenitor cells early in development and led to hypomethylation of the pancreatic epithelial cells.
We next examined the effects of Dnmt1 deletion on pancreatic organogenesis by analyzing DNMT1 PC litters at birth. DNMT1 PC animals were born alive at expected Mendelian ratios. Examination of littermates indicated that the pancreas of pups in which one allele of Dnmt1 was deleted were grossly normal and comparable with wild-type control littermates ( Fig. 1 A,B , D,E). YFP expression was absent in the control animals and homogenously distributed throughout the pancreas in heterozygous pups (Fig. 1G,H) . Strikingly, gross examination of the DNMT1 PC pancreas revealed a severely atrophic pancreas (Fig. 1C,F) . The rudimentary DNMT1 PC pancreas displayed little YFP expression, indicating that most of the atrophic pancreatic tissue was derived from cells that had escaped recombination (Fig. 1I ). These data indicated that Dnmt1 is essential for the formation of the pancreas.
Previous studies in zebrafish indicated that loss of Dnmt1 resulted in degeneration of the acinar pancreas, but ductal and endocrine lineages were spared, leaving open the possibility that the atrophic pancreas that we observed could consist of primarily endocrine and ductal cells (Anderson et al. 2009 ). To determine whether the absence of Dnmt1 resulted in loss of specific cell lineages, we carried out immunohistological analysis for differentiated cell types in the DNMT1 PC pancreas. Antibody staining against exocrine cells expressing amylase and endocrine cells expressing insulin showed that scattered clusters of both endocrine and exocrine cells were present in the DNMT1 PC pancreas, but the typical rosette architecture of the acinar tissue and islet clusters of insulin cells was disrupted (Supplemental Fig. S2A-D) . Cells that stained for the ductal marker mucin were scattered throughout the DNMT1 PC pancreas (data not shown). From this analysis, we concluded that deletion of Dnmt1 from pancreatic epithelial progenitor cells did not impact any particular lineage and instead disrupted the architecture and severely reduced the numbers of differentiated cells of all lineage of the mature pancreas.
Deletion of Dnmt1 in pancreatic progenitors results in the absence of differentiated cells
We investigated whether a severely reduced pancreas size could result from depletion of the pancreatic progenitor pool during embryogenesis. We examined DNMT1 PC and control littermate pancreas by immunostaining for pancreatic progenitor markers Pdx1 and Sox9. At E13.5, the overlapping Pdx1 and Sox9 populations were comparable in the control and DNMT1
PC pancreatic epithelium (P = 0.2568) ( Fig. 2A ,B,E). In contrast, the number of cells staining for Sox9 at E15.5 was reduced by >40% in the DNMT1 PC pancreas compared with the control littermate pancreas (P = 0.0137) (Fig. 2C ,D,E). This indicated that the progenitor pool is depleted during pancreatic organogenesis and results in a severely atrophic pancreas. The depletion of pancreatic progenitors could be due to either a defect in self-renewal or precocious differentiation. Precocious differentiation leading to depletion of the pancreatic progenitor pool has been previously described (Jensen et al. 2000b; Bhushan et al. 2001) . To assess precocious differentiation, we carried out immunohistochemistry of E12.5 pancreas with antibodies against Sox9 to mark progenitor cells and glucagon to mark differentiated cells. The size of the pancreatic epithelial bud and the number of glucagon cells from E12.5 embryos immunostained with Sox9 and glucagon were comparable in DNMT1 PC and control littermates ( Fig. 2F-G) . To further assess differentiation, we compared global gene expression by microarray analysis in control and DNMT1 PC pancreas. There was less than a twofold difference between most transcripts in the control and DNMT1 PC pancreas, which suggests that the majority of the cells in the DNMT1 PC pancreas had a transcriptome similar to that of the control pancreas (Supplemental Fig. 3A) . Gene enrichment analysis indicated that a subset of genes involved in pancreatic differentiation was specifically down-regulated. Neurogenin 3, the gene required for differentiation of all endocrine cell types, was one of the most down-regulated gene in the array analysis, with a >12-fold decrease in expression in the DNMT1 PC Cold Spring Harbor Laboratory Press on October 19, 2017 -Published by genesdev.cshlp.org Downloaded from pancreas (Schwitzgebel et al. 2000) . Other transcription factors involved in endocrine and exocrine lineage specification-such as Nkx6.1, Nkx2.2, Rfx6, Rbjk-l, and Ptf1-were specifically down-regulated (Supplemental Fig. 3B ). We sought to confirm the gene expression profiles by immunohistochemistry. Immunostaining of the control pancreas at E15.5 showed Ngn3
+ cells along the embryonic duct surrounded by pancreatic progenitor cells expressing Pdx1. In striking contrast, the number of Ngn3
+ cells in the DNMT1 PC pancreas was <15% that of the control littermates (P < 0.005) (Fig. 2H-J) . These results indicated that in the absence of Dnmt1, pancreatic epithelial cells were not depleted due to precocious differentiation, and in fact, very few differentiated cells were observed in the DNMT1 PC pancreas.
Loss of Dnmt1 resulted in accumulation of progenitor cells in the G2 phase
To investigate whether loss of Dnmt1 resulted in depletion of pancreatic progenitor cells due to defects in self-renewal, we analyzed embryos from pregnant dams injected with a short pulse of BrdU. Control and DNMT1 PC pancreas were immunostained with antibodies against Pdx1 to mark pancreatic progenitor cells and BrdU to identify cells actively in S phase of the cell cycle (Fig. 3A,B) . The Pdx1 + BrdU + cells were counted to determine the proliferation index, calculated as (Pdx1 + BrdU + )/Pdx1 + . There were no differences in the proliferation index between control and DNMT1 PC progenitor cells at E12.5 (Fig. 3C) . Because a short BrdU pulse only measures the cells that are actively in S phase, we pursued additional proliferation studies to determine whether the progenitor cells were completing the cell cycle. Control and DNMT1
PC pancreas were immunostained with antibodies against phosphorylated histone H3, a marker for G2/M phase, and Pdx1 (Fig. 3D,E) . Cells with a speckled PHH3 pattern were categorized as G2 phase of the cell cycle (Fig. 3D ,E, white arrows), and cells with more robust staining were categorized as M phase (Fig. 3D,E, 
orange arrows). Ratios of Pdx1
+ PHH3 + /Pdx1 + were used to calculate the proliferation index. Comparing control and DNMT1 PC pancreas revealed that the number of M-phase progenitor cells was not significantly different, but the number of progenitor cells in G2 phase in the DNMT1 PC pancreas was increased by 40% (P < 0.005) (Fig 3F) . The fact that S-phase and M-phase progenitor cells did not change in the DNMT1 PC pancreas indicated that cell cycle entry and mitosis of pancreatic epithelial cells were not perturbed by the deletion of Dnmt1. The accumulation of a subset of pancreatic epithelial cells in G2 arrest suggested that depletion of these cells could be due to apoptosis.
Deletion of Dnmt1 results in p53-dependent apoptosis of pancreatic progenitors
We next investigated whether apoptosis of pancreatic epithelial cells could result in the atrophic phenotype of the DNMT1 PC pancreas at birth. Pancreatic sections from E15.5 DNMT1 PC and control littermate embryos were stained for cleaved caspase 3, a marker for apoptosis, and Pdx1. Cleaved caspase 3 was not detected in control pancreas; however, DNMT1 PC pancreas showed a number of cells within the pancreatic epithelium that were positive for cleaved caspase 3 (Fig. 4A,B) .
Several studies in fibroblast and cancer cell lines indicated that loss of Dnmt1 resulted in p53-dependent apoptosis, although the mechanism remains unclear (Jackson-Grusby et al. Chen et al. 2007; Anderson et al. 2009 ). To determine whether deletion of Dnmt1 in pancreatic progenitors resulted in changes in p53, we first assessed whether levels of p53 were altered in DNMT1 PC pancreas. Immunohistochemical analysis using a p53 antibody revealed that p53 accumulated in the DNMT1 PC epithelium, while no p53 staining was observed in control littermate pancreas (Fig. 4C,D , white arrows). To confirm this accumulation of p53 in DNMT1 PC pancreas, we measured p53 using Western blot analysis at E12.5, prior to detectable differences in the pancreatic epithelium, and at E15.5, after the onset of p53 expression. Western blot analysis indicated that there was no difference in the accumulation of p53 at E12.5, but there was a significant sixfold increase in p53 in the DNMT1 PC pancreas compared with control pancreas from littermates at E15.5 (P = 0.0098) (Fig 4E,F) . Western blot analysis indicated that the p53 downstream transcriptional target p21 accumulated in the DNMT1 PC pancreas (Fig. 4E) . To assess whether the increase in p53 protein correlated with an increase in mRNA levels of p53, we used quantitative PCR to quantify any changes in p53 gene expression. Our analysis revealed a 20-fold increase in p53 mRNA in DNMT1
PC pancreas compared with control pancreas from littermates (data not shown). The increase in p53 mRNA indicated that Dnmt1 could potentially regulate p53 at a transcriptional level.
We next assessed how loss of Dnmt1 resulted in transcriptional up-regulation of p53. We hypothesized that DNMT1 could play a role in directly repressing p53 transcription and that loss of Dnmt1 would result in derepression of p53. Supporting our hypothesis, a previous study showed that DNMT1 was bound to the p53 promoter 2 kb upstream of the p53 transcription start site. Interestingly, this upstream regulatory region also contained a binding sequence for the transcriptional repressor CTCF. Binding of CTCF to this region suppressed reporter activity (Su et al. 2009 ). We reasoned that DNMT1 and CTCF associated at the p53 regulatory region, and binding of CTCF to the p53 regulatory region may be disrupted in the absence of Dnmt1. To test this, E14.5 pancreas from DNMT1 PC and control littermates were subjected to chromatin immunoprecipitation (ChIP) analysis (Fig. 4G) . In control pancreas, both DNMT1 and CTCF were bound to the p53 regulatory region, confirming that DNMT1 and CTCF binding was associated with p53 repression (P < 0.005) (Fig. 4H) . In contrast, there was no enrichment of CTCF in DNMT1
PC embryos (P = 0.0268) (Fig. 4H) . Moreover, enrichment of H3K27ac within the p53 promoter region was observed in the DNMT1 PC embryos, which is consistent with transcriptional activation (P = 0.0423) (Fig. 4H) . These results suggested that DNMT1 directly repressed p53 transcription, and loss of Dnmt1 resulted in derepression of p53.
Haploinsufficiency of p53 rescues pancreatic organogenesis
To investigate whether inactivation of Dnmt1 resulted in p53-mediated apoptosis of pancreatic progenitors, we crossed the p53-null animals into the DNMT1 PC background. p53-null animals are phenotypically indistinguishable from wild-type littermates at birth, and pancreas formation was not perturbed (Jacks et al. 1994) .
We first assessed whether haploinsufficiency of p53 restored pancreatic progenitor popula- PC pancreas. Chromatin insulator protein CTCF is also bound to the p53 locus in control pancreas but is lost in the DNMT1 PC pancreas. The activating histone mark H3K27ac is enriched in the DNMT1 PC pancreas.
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Cold Spring Harbor Laboratory Press on October 19, 2017 -Published by genesdev.cshlp.org Downloaded from tions at E15.5. Immunohistochemical assessment of Sox9 and Pdx1 revealed no significant differences in the pancreatic epithelium between the control and DNMT1 PC p53 +/À pancreas (Fig. 5A,B) . To evaluate whether p53 haploinsufficiency would restore the expression of ngn3, we examined DNMT1 PC p53 +/À pancreas for expression of Ngn3. Immunohistochemistry at E16.5 indicated that Ngn3
+ and Pdx1 + cell populations persisted through organogenesis with a staining pattern similar to that of control littermates. Lineage tracing indicated that DNMT1 PC p53 +/À cells expressing Ngn3 had undergone recombination, thus leading us to conclude that the expression of Ngn3 was restored by p53 haploinsufficiency (Fig. 5C,D) . At birth, DNMT1 PC and DNMT1 PC p53 +/À animals were present at the expected Mendelian ratios. Gross histological examination of the neonatal pancreas revealed that while the pancreas of DNMT1 PC animals were severely atrophic, DNMT1 PC p53 +/À littermates had a restoration of a full, albeit smaller, pancreas (Fig. 5E,F) . Lineage tracing suggested that recombination was extensive, although not complete, in the DNMT1 PC p53
+/À background (Fig. 5G,H ). Insulin and YFP immunostaining indicated normal morphology of the endocrine tissue compartment in the control and DNMT1 PC p53 +/À littermate pancreas (Supplemental Fig. 4A,B) . Immunostaining for amylase and YFP indicated that exocrine cells formed morphologically normal rosette structures (Supplemental Fig. 4C,D) . Mucin + /YFP + ductal structures were present and morphologically normal in both the control and DNMT1 PC p53 +/À pancreas (Supplemental Fig. 4E,F) . Taken together, these data indicated that p53 haploinsufficiency rescued the ability of Dnmt1-null pancreatic progenitor cells to differentiate into a normal mature organ during embryogenesis. The area of DNMT1 PC p53
+/À islets decreased by postnatal day 15, and blood glucose levels were elevated into the diabetic range. This suggests that while haploinsufficiency of p53 may permit organogenesis in the DNMT1 PC pancreas, these cells are not able to support glucose homeostasis in adolescent mice (Supplemental Fig. 5A-E) .
Our results suggest that p53 repression mediated by DNMT1 is not required for self-renewal of pancreatic progenitor cells per se but is critical for progenitor cell survival during differentiation. Furthermore, p53 haploinsufficiency prevented apoptosis and rescued the survival of Dnmt1-null progenitor cells; this suggests that p53 is a primary target of DNMT1 action in pancreatic progenitor cells. Recently, the role of Dnmt1 in epidermal progenitor cells suggested that Dnmt1 was required to retain proliferative stamina and suppress differentiation (Sen et al. 2010) . Deletion of Dnmt1 in epidermal progenitors resulted in precocious differentiation and eventual tissue loss. Although the phenotype in the pancreatic deletions of Dnmt1 also was the eventual loss of tissue, no evidence of premature differentiation or defects in proliferation were observed. The mechanism by which Dnmt1 maintains progenitor populations may vary in different tissue depending on the cellular context. This suggests that at a molecular level, DNMT1 may associate with different effectors to carry out repressive functions depending on the cellular context.
We attribute the inability of the DNMT1 PC pancreatic progenitor population to undergo differentiation to the accumulation of p53. Part of p53 accumulation may be due to the derepression of the p53 locus when DNMT1 is not present on the promoter. It is to be noted that there is no CpG methylation around the DNMT1-CTCFbinding area (Su et al. 2009 ; our unpublished results), suggesting that DNMT1 is working as part of a repressive complex independent of its DNA methylation activity. Methylation-independent functions of DNMT1 have been shown to repress target genes as part of complexes with E2F1 and histone deacetylases (Valdez et al. 2011; Clements et al. 2012) . The inability of DNMT1 PC cells to differentiate because of derepression of p53 is similar to the mdm2 À/À mouse phenotype (Jones et al. 1995; Montes de Oca Luna et al. 1995) . While mdm2 À/À are embryonic-lethal at E6.5, mdm2
À/À compound mutants are normal and viable. Analysis of compound mdm2
515c-515c , which express a mutated p53 that can mediate growth arrest but not apoptosis, revealed hematapoetic and lymphoid deficiencies because of progenitor cell cycle and differentiation defects (Liu et al. 2007 ). Thus, it is possible that repression of p53 serves to facilitate pancreatic progenitor cell differentiation during normal organogenesis and that the absence of Dnmt1 results in transcriptional derepression and subsequent accumulation of p53 that initiates cell cycle arrest and apoptosis during differentiation. The ability of DNMT1 PC p53 +/À pancreatic progenitor cells to persist through differentiation and form a pancreas at birth suggests that Dnmt1 is not required to maintain progenitor cell self-renewal or differentiation but is required to attenuate the role of p53 as a checkpoint during differentiation.
Materials and methods
Information on mouse strains is in the Supplemental Material. All animal experiments were performed in accordance with NIH policies on the use of laboratory animals and approved by the Animal Research Committee of the Office for the Protection of Research Subjects at University of California at Los Angeles. For immunohistochemical experiments, tissues were prepared, oriented, and stained, and images were captured as previously described (Georgia et al. 2006) . Calculations of the proliferative index were done as previously described using at least three embryos from each genotype (Zhong et al. 2007) . ChIP experiments with the E14.5 dorsal pancreas cells were carried out using the micro-ChIP protocol (Dahl and Collas 2008) . Statistical significance was determined using Student's t test. Information on mouse strains, antibodies, and primers is in the Supplemental Material.
